Sio Capital Management as of Dec. 31, 2017
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 43 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sage Therapeutics (SAGE) | 16.6 | $30M | 179k | 164.71 | |
| GlaxoSmithKline | 6.5 | $12M | 326k | 35.47 | |
| Aetna | 5.9 | $11M | 58k | 180.40 | |
| Anthem (ELV) | 5.6 | $10M | 44k | 225.01 | |
| Quotient | 4.0 | $7.1M | 1.4M | 4.95 | |
| Intuitive Surgical (ISRG) | 3.9 | $6.9M | 19k | 365.00 | |
| UnitedHealth (UNH) | 3.9 | $6.9M | 31k | 220.47 | |
| Kura Oncology (KURA) | 3.4 | $6.0M | 392k | 15.30 | |
| Viking Therapeutics (VKTX) | 2.9 | $5.1M | 1.3M | 4.06 | |
| On Assignment | 2.8 | $4.9M | 77k | 64.27 | |
| Cardinal Health (CAH) | 2.8 | $4.9M | 80k | 61.28 | |
| Trinet (TNET) | 2.8 | $4.9M | 110k | 44.34 | |
| WellCare Health Plans | 2.6 | $4.7M | 23k | 201.12 | |
| Premier (PINC) | 2.6 | $4.7M | 160k | 29.19 | |
| Eli Lilly & Co. (LLY) | 2.6 | $4.6M | 54k | 84.45 | |
| Emergent BioSolutions (EBS) | 2.4 | $4.3M | 92k | 46.48 | |
| Boston Scientific Corporation (BSX) | 2.1 | $3.7M | 150k | 24.79 | |
| Hca Holdings (HCA) | 2.1 | $3.7M | 42k | 87.84 | |
| Pfizer (PFE) | 2.0 | $3.6M | 100k | 36.22 | |
| Rigel Pharmaceuticals (RIGL) | 1.9 | $3.4M | 885k | 3.88 | |
| Mednax (MD) | 1.7 | $3.0M | 57k | 53.45 | |
| Catalyst Biosciences | 1.6 | $2.8M | 202k | 13.64 | |
| Advanced Accelerat spon ads each rep 2 ord | 1.5 | $2.7M | 33k | 81.62 | |
| Icon (ICLR) | 1.5 | $2.6M | 24k | 112.14 | |
| Koninklijke Philips Electronics NV (PHG) | 1.4 | $2.6M | 68k | 37.80 | |
| Gw Pharmaceuticals Plc ads | 1.4 | $2.5M | 19k | 132.00 | |
| Ligand Pharmaceuticals In (LGND) | 1.4 | $2.5M | 18k | 136.94 | |
| Xencor (XNCR) | 1.4 | $2.4M | 110k | 21.92 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.3 | $2.2M | 15k | 149.86 | |
| Natus Medical | 1.1 | $2.0M | 53k | 38.21 | |
| Mei Pharma | 1.0 | $1.7M | 827k | 2.10 | |
| Vocera Communications | 0.9 | $1.7M | 56k | 30.22 | |
| Odonate Therapeutics Ord | 0.7 | $1.3M | 50k | 25.00 | |
| Puma Biotechnology (PBYI) | 0.7 | $1.2M | 12k | 98.86 | |
| Adamas Pharmaceuticals | 0.7 | $1.2M | 35k | 33.89 | |
| Myovant Sciences | 0.5 | $923k | 73k | 12.63 | |
| Foamix Pharmaceuticals | 0.4 | $789k | 131k | 6.01 | |
| Computer Programs & Systems (TBRG) | 0.4 | $738k | 25k | 30.07 | |
| Progenics Pharmaceuticals | 0.3 | $497k | 84k | 5.95 | |
| Chemocentryx | 0.3 | $496k | 83k | 5.95 | |
| Quality Systems | 0.1 | $247k | 18k | 13.57 | |
| Steadymed | 0.1 | $203k | 55k | 3.69 | |
| Oasmia Pharmaceutical Ab | 0.1 | $179k | 203k | 0.88 |
